Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data

Background Psoriasis-related pruritus (PRP) in patients under systemic treatment is challenging. The risk to switch anti-psoriatic drugs and to lose response to previous therapy is high, thus dermatologists prefer to add an anti-pruritic agent. Objectives To evaluate the effect of anti-histamines an...

Full description

Bibliographic Details
Main Authors: Giovanni Damiani, Khalaf Kridin, Alessia Pacifico, Piergiorgio Malagoli, Paolo D. M. Pigatto, Renata Finelli, Fabio S. Taccone, Lorenzo Peluso, Rosalynn R. Z. Conic, Nicola L. Bragazzi, Young Dermatologists Italian Network, Marco Fiore
Format: Article
Language:English
Published: Taylor & Francis Group 2022-04-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2020.1840502